West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,400 | 203,000 | 205,900 | 202,700 | 178,100 |
| Receivables | 224,800 | 200,500 | 209,500 | 219,000 | 209,600 |
| Inventories | 212,300 | 199,300 | 201,100 | 197,700 | 194,100 |
| Other current assets | 46,100 | 39,100 | 41,600 | 39,800 | 48,900 |
| TOTAL | $652,600 | $641,900 | $658,100 | $659,200 | $630,700 |
| Non-Current Assets | |||||
| PPE Net | 782,800 | 778,300 | 772,700 | 741,200 | 732,500 |
| Investments And Advances | 81,300 | 82,700 | 81,400 | 77,700 | 61,600 |
| Intangibles | 126,600 | 126,300 | 129,600 | 129,800 | 131,500 |
| Other Non-Current Assets | 90,200 | 87,500 | 93,500 | 97,200 | 111,900 |
| TOTAL | $1,080,900 | $1,074,800 | $1,077,200 | $1,045,900 | $1,037,500 |
| Total Assets | $1,733,500 | $1,716,700 | $1,735,300 | $1,705,100 | $1,668,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106,100 | 122,000 | 99,000 | 107,300 | 97,500 |
| Accrued Expenses | 43,900 | 51,600 | 58,900 | 55,100 | 43,100 |
| Other current liabilities | 65,900 | 60,500 | 73,100 | 65,200 | 80,100 |
| TOTAL | $256,500 | $241,000 | $236,800 | $239,400 | $241,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 194,200 | 226,200 | 228,600 | 228,900 | 229,500 |
| aiOther Non-Current Liabilities | 104,400 | 122,800 | 112,400 | 112,900 | 110,100 |
| TOTAL | $308,400 | $358,200 | $356,200 | $356,300 | $353,100 |
| Total Liabilities | $564,900 | $599,200 | $593,000 | $595,700 | $594,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,554 | 73,260 | 73,184 | 73,218 | 73,078 |
| Common Shares | 18,600 | 18,400 | 18,400 | 18,400 | 18,300 |
| Retained earnings | 1,118,800 | 1,071,600 | 1,041,900 | 1,013,800 | 978,000 |
| Other shareholders' equity | -178,800 | -186,900 | -143,600 | -150,400 | -147,800 |
| TOTAL | $1,168,600 | $1,117,500 | $1,142,300 | $1,109,400 | $1,074,000 |
| Total Liabilities And Equity | $1,733,500 | $1,716,700 | $1,735,300 | $1,705,100 | $1,668,200 |